205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
7.43%
Net income growth under 50% of MCHP's 142.11%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
157.48%
Lower 'other non-cash' growth vs. MCHP's 635.71%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
316.99%
Operating cash flow growth above 1.5x MCHP's 50.00%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
93.62%
CapEx growth well above MCHP's 17.33%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-225.00%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-80.00%
Both yoy lines are negative, with MCHP at -70.48%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-2283.33%
We reduce yoy other investing while MCHP is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
43.23%
We have mild expansions while MCHP is negative at -3.33%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-29.41%
Negative yoy issuance while MCHP is 400.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.